**7. References**


Arutchelvi J & Doble M (2010) Mannosylerythritol lipids: microbial production and their

Arutchelvi JI, Bhaduri S, Uppara PV & Doble M (2008) Mannosylerythritol lipids: a review.

Banat IM (1995a) Biosurfactants production and use in microbial enhanced oil recovery and

Banat IM (1995b) Biosurfactants characterization and use in pollution removal; state of the

Banat IM, Franzetti A, Gandolfi I, Bestetti G, Martinotti MG, Fracchia L, Smyth TJ &

Banat IM, Makkar RS & Cameotra SS (2000) Potential commercial applications of microbial

Barrons R & Tassone D (2008) Use of *Lactobacillus* probiotics for bacterial genitourinary

Basak P, Adhikari B, Banerjee I & Maiti TK (2009) Sustained release of antibiotic from polyurethane coated implant materials. *J Mater Sci Mater Med.* 20:S213–S221 Becher P (Ed.) (1965) *Emulsions, Theory and practice*, Reinhold Publishing, New York, USA. Benincasa M, Abalos A, Oliveira I & Manresa A (2004) Chemical structure, surface

Bernheimer AW & Avigad LS (1970) Nature and properties of a cytolytic agent produced by

Besson, F, Peypoux F, Michel G, & Delcambe L (1978). Identification of antibiotics of iturin group in various strains of *Bacillus subtilis*. *J. Antibiot*. (Tokyo) 31:284–288 Besson F et al. (1976) Characterisation of iturin A in antibiotics from various strains of

Biria D, Maghsoudi E, Roostaazad R, Dadafarin H, Lotfi AS & Amoozegar MA (2010)

Bodour AA, Miller-Maier RM (1998) Application of a modified drop-collapse technique for

Boisselier E & Astruc D (2009) Gold nanoparticles in nanomedicine: preparations, imaging,

Bonmatin JM, Laprevote O & Peypoux F (2003) Diversity among microbial cyclic

Bouffioux O, Berquand A, Eeman M, Paquot M, Dufrêne YF, Brasseur R & Deleu M (2007)

Brasseur R, Braun N, El Kirat K, Deleu M, Mingeot-Leclercq MP & Dufrêne YF (2007) The

Purification and characterization of a novel biosurfactant produced by *Bacillus* 

surfactant quantitation and screening of biosurfactant-producing microorganisms.

lipopeptides: iturins and surfactins. Activity-structure relationships to design new

Molecular organization of surfactin-phospholipid monolayers: effect of phospholipid chain length and polar head. *Biochim Biophys Acta Biomembr*.

biologically important surfactin lipopeptide induces nanoripples in supported lipid

Marchant R (2010) Microbial biosurfactants production, applications and future

properties and biological activities of the biosurfactant produced by *Pseudomonas* 

pollution remediation: A review. *Bioresource Technol*. 51:1-12

pp. 145-177, Springer, Münster, Germany

art. A review. *ACTA Biotechnologica.* 15:251-26

potential. *Appl Microbiol Biotechnol.* 87:427-44.

*Bacillus subtilis. J Gen Microbiol.* 6:361-366

*Bacillus subtilis*. *J. Antibiot* 29: 1043–1049

*J. Microbiol Methods.* 32:273-280

bilayers. *Langmuir* 23:9769–9772

1768:1758–1768

surfactants. *Appl Microbiol Biotechnol*. 53:495–508

infections in women: a review. *Clin Ther.* 30:453-468

*aeruginosa* LBI from soapstock. *Anton Leeuw Int J G.* 85:1–8

*licheniformis* MS3. *World J Microbiol Biotechnol.* 26:871–878

diagnostics, therapies and toxicity. *Chem Soc Rev.* 38:1759–1782

bioactive agents. *Comb Chem High Throughput Screen.* 6:541-556

*J Ind Microbiol Biotechnol.* 35:1559–1570

applications, In: *Biosurfactants: From Genes to Applications,* Soberón-Chávez G Ed.,


Cosson P, Zulianello L, Join-Lambert O, Faurisson F, Gebbie L, Benghezal M, van Delden C,

Cribby S, Taylor M & Reid G (2008) Vaginal microbiota and the use of probiotics. *Interdisciplinary perspectives on infectious diseases*. Article ID 256490, 9 pages. Das P, Mukherjee S & Sen R (2008) Antimicrobial potential of a lipopeptide biosurfactant derived from a marine *Bacillus circulans*. *J Appl Microbiol.* 104:1675–1684 Dastgheib SMM, Amoozegar MA, Elahi E, Asad S & Banat IM (2008) Bioemulsifier

Deleu M, Paquot M & Nylander T (2008) Effect of fengycin, a lipopeptide produced by

Dempsey KE, Riggio MP, Lennon A, Hannah VE, Ramage G, Allan D & Bagg J (2007)

Desai JD & Banat IM (1997) Microbial production of surfactants and their commercial

Donadio S, Monciardini P, Alduina R, Mazza P, Chiocchini C, Cavaletti L, Sosio M & Puglia

Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant

Eeman M, Francius G, Dufrêne YF, Nott K, Paquot M & Deleu M (2009) Effect of cholesterol

Faivre V & Rosilio V (2010) Interest of glycolipids in drug delivery: from physicochemical

Falagas ME, Betsi GE, Tokas T & Athanassiou S (2006a) Probiotics for prevention of

Falagas ME, Betsi GI & Athanasiou S (2007) Probiotics for the treatment of women with

Falagas ME, Betsi GI, Athanasiou S (2006b) Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. *Antimicrob Chemother*. 58:266-272. Falagas ME & Makris GC (2009) Probiotic bacteria and biosurfactants for nosocomial

Fassi FL, Wroblewski H & Blanchard A (2007) Activities of antimicrobial peptides and

Federle MJ & Bassler BL (2003) Interspecies communication in bacteria. *J Clin Invest.*

Fracchia L, Cavallo M, Allegrone G & Martinotti MG (2010) A *Lactobacillus*-derived

synergy with enrofloxacin against *Mycoplasma pulmonis. Antimicrob Agents* 

biosurfactant inhibits biofilm formation of human pathogenic *Candida albicans* biofilm producers, In: *Current Research, Technology and Education Topics in Applied* 

properties to drug targeting *Expert Opin Drug Deliv.* 7(9):1031-1048

Dictyostelium discoideum *host system.* J Bacteriol*. 184(11):3027-3033*

microbially enhanced oil recovery. *Biotechnol Lett.* 30(2):263-270

*Bacillus subtilis*, on model biomembranes. *Biophys J*. 94:2667–2679

sequencing and by microbiological culture. *Arthritis Res Ther.* 9:R46

potential. *Microbiol Mol Biol Rev.* 61:47–64

microorganisms. *Clin Microbiol Rev.* 15: 167-193

mimicking lipid monolayers. *Langmuir.* 25:3029–3039

microbiological and clinical studies. *Drugs*. 66:1253-1261.

infection control: a hypothesis. *J Hosp Infect*. 71(4):301-306

bacterial vaginosis. *Clin Microbiol Infect.* 13: 657–664

*Biotechnol.* 99:187–198

*Chemother*. 51:468-74

112:1291–1299

Curty LK & Köhler T *(2002)* Pseudomonas aeruginosa *virulence analyzed in a* 

production by a halothermophilic *Bacillus* strain with potential applications in

Identification of bacteria on the surface of clinically infected and noninfected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene

AM (2002) Microbial technologies for the discovery of novel bioactive metabolite. *J* 

and fatty acids on the molecular interactions of fengycin with stratum corneum

recurrent urinary tract infections in women: a review of the evidence from

*Microbiology and Microbial Biotechnology* (vol. 2), Mendez Vilas A Ed., pp. 827-837, FORMATEX, Spain


soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. *Antimicrob Agents Chemother*. 52: 171-182


Imura T, Ito S, Azumi R, Yanagishita H, Sakai H, Abe M & Kitamoto D (2007) Monolayers

Imura T, Masuda Y, Ito S, Worakitkanchanakul W, Morita T, Fukuoka T, Sakai H, Abe M &

Inoh Y, Furuno T, Hirashima N & Nakanishi M (2009) Nonviral vectors with a biosurfactant

Inoh Y, Furuno T, Hirashima N, Kitamoto D & Nakanishi M (2010) The ratio of unsaturated

Inoh Y, Kitamoto D, Hirashima N & Nakanishi M (2001) Biosurfactants of MEL-A increase

Inoh Y, Kitamoto D, Hirashima N & Nakanishi M (2004) Biosurfactant MEL-A dramatically increases gene transfection via membrane fusion. *J Control Release* 94:423–431. Ishigami Y & Suzuki S (1997) Development of biochemicals—functionalization of

Ito S, Imura T*,* Fukuoka T, Morita T, Sakai H, Abea M & Kitamoto D (2007) Kinetic studies

Jaques P (2010) Surfactin and other lipopeptides from *Bacillus* spp. In: *Biosurfactants: From* 

Jung M, Lee S & Kim H (2000) Recent studies on natural products as anti-HIV agents. *Curr* 

Kalishwaralal K, Deepak V, Pandiana SBRK, Kottaisamy M, BarathManiKanth S, Kartikeyan

Kalmokoff ML, Austin JW, Wan XD, Sanders G, Banerjee S & Farber JM (2001) Adsoption,

Kim BS, Lee JY & Hwang BK (2000) *In vivo* control and *in vitro* antifungal activity of

Kim H, Ryu JH & Beuchat LR (2006) Attachment of and biofilm formation by *Enterobacter* 

Kim K, Yoo D, Kim Y, Lee B, Shin D & Kim E-K (2002) Characteristics sophorolipid as an

biosurfactants and natural dyes. *Prog Org Coatings.* 31:51–61.

*Brevibacterium casei. Colloids Surf B Biointerfaces.* 77:257–262

model conditions. *J Appl Microbiol.* 91:725–734

*Colletotrichum orbiculare. Pest Manag Sci.* 56:1029-1035

antimicrobial agent. *J Microbiol Biotechnol.* 12:235-241

lens care solutions. *Antimicrob Agents Chemother*. 52: 171-182

29:865–870

57:415-22

289:57–61

Germany

72:5846–5856

cavity. *Biol Pharm Bull.* 32:126—128

*Pharmaceut*. 398:225–230

*B Biointerfaces*. 58:165–171

*Med Chem*. 7:649-661

soft contact lenses: model development, influence of lens type, and susceptibility to

assembled from a glycolipid biosurfactant from *Pseudozyma* (*Candida*) *antarctica* serve as a high-affinity ligand system for immunoglobulin G and M. *Biotechnol Lett*.

Kitamoto D (2008) Packing density of glycolipid biosurfactant monolayers give a significant effect on their binding affinity toward immunoglobulin G. *J Oleo Sci*.

MEL-A promote gene transfection into solid tumors in the mouse abdominal

fatty acids in biosurfactants affects the efficiency of gene transfection. *Int J* 

gene transfection mediated by cationic liposomes. *Biochem Biophys Res Commun*.

on the interactions between glycolipid biosurfactant assembled monolayers and various classes of immunoglobulins using surface plasmon resonance. *Colloids Surf* 

*Genes to Applications,* Soberón-Chávez G Ed., pp. 57-91, Springer, Münster,

B & Gurunathan S (2010) Biosynthesis of silver and gold nanoparticles using

attachment and biofilm formation among isolates of *Listeria monocytogenes* using

rhamnolipid B, a glycolipid antibiotic, against *Phytophthora capsici* and

*sakazakii* on stainless steel and enteral feeding tubes. *Appl Environ Microbiol*.


Lu JR, Zhao XB & Yaseen M (2007) Biomimetic amphiphiles: biosurfactants. *Curr Opin* 

Luna JM, Rufino RD, Sarubbo LA, Rodrigues LR, Teixeira JA & de Campos-Takaki GM

Maitani Y, Yano S, Hattori Y, Furuhata M & Hayashi K (2006) Liposome vector containing

Martinotti MG, Rivardo F Allegrone G, Ceri H, Turner R (2009) Biosurfactant composition

Matsuyama T, Tanikawa T, & Nakagawa Y (2010) Serrawettins and other surfactants

McInerney MJ, Javaheri M & Nagle DP (1990) Properties of the biosurfactant produced by

Merk K, Borelli C & Korting HC (2005) Lactobacilli—bacteria–host interactions with special

Meurman JH (2005) Probiotics: do they have a role in oral medicine and dentistry? *Eur J Oral* 

Meurman JH & Stamatova I (2007) Probiotics: contributions to oral health. *Oral Dis.* 13:443–

Meylheuc T, Methivier C, Renault M, Herry JM, Pradier CM & Bellon-Fontaine MN (2006a)

Meylheuc T, Renault M & Bellon-Fontaine MN (2006b) Adsorption of a biosurfactant on

Mimee B, Labbé C, Pelletier R & Bélanger RR (2005) Antifungal activity of flocculosin, a

Mimee B, Pelletier R & Bélanger RR (2009) In vitro antibacterial activity and antifungal

Mireles JR II, Toguchi A & Harshey RM (2001) *Salmonella enterica* serovar *typhimurium*

Mohammad Abdel-Mawgoud A, Hausmann R, Lépine F, Müller MM & Déziel E (2010)

Morikawa M (2006) Beneficial biofilm formation by industrial bacteria *Bacillus subtilis* and

Adsorption on stainless steel surfaces of biosurfactants produced by gram-negative and gram-positive bacteria: consequence on the bioadhesive behavior of *Listeria* 

surfaces to enhance the disinfection of surfaces contaminated with *Listeria* 

novel glycolipid isolated from *Pseudozyma flocculosa. Antimicrob Agents Chemother.*

mode of action of flocculosin, a membrane-active cellobiose lipid. *J Appl Microbiol.*

swarming mutants with altered biofilm forming abilities: surfactin inhibits biofilm

Rhamnolipids: detection, analysis, biosynthesis, genetic regulation, and bioengineering of production, In: *Biosurfactants: From Genes to Applications,* Soberón-

*Bacillus liqueniformis* strain JF-2. *I. J. Microbiol Biotechnol*. 5:95–102

regard to the urogenital tract. *Int J Med Microbiol*. 295:9–18

*monocytogenes*. *Colloids Surf B Biointerfaces.*52:128–137

Chávez G Ed., pp. 13-55, Springer, Münster, Germany

*monocytogenes*. *Int J Food Microbiol.* 109:71–78

formation. *J Bacteriol.* 183:5848–5854

related species. *J Biosci Bioeng.* 101:1–8

(2011) Evaluation antimicrobial and antiadhesive properties of the biosurfactant lunasan produced by *Candida sphaerica* UCP 0995. *Curr Microbiol.* 62:1527-1534 Maier RM (2003) Biosurfactants: evolution and diversity in bacteria. *Adv Appl Microbiol*. 52:

biosurfactant-complexed DNA as herpes simplex virus thymidine kinase gene

produced by a new *Bacillus licheniformis* strain, uses and products thereof.

produced by *Serratia*. In: *Biosurfactants: From Genes to Applications,* Soberón-Chávez

*Colloid Interface Sci*. 12:60-67

delivery system. *J Liposome Res.* 16:359-72.

International patent PCT/IB2009/055334, 25 November

G Ed., pp. 93-120, Springer, Münster, Germany

101-121

*Sci.* 113:188–196

49:1597–1599

107:989–996

445


Nitschke M, Costa SG & Contiero J (2010) Structure and applications of a rhamnolipid surfactant produced in soybean oil waste. *Appl Biochem Biotechnol.* 160(7):2066-74 Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á & Aranda FJ (2008) Interactions of a

Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á & Aranda FJ (2009) Interactions of a

Osada, H (1998) Bioprobe for investigating mammlian cell cycles control. *J. Antibiotics*

Palanisamy P (2008) Biosurfactant mediated synthesis of NiO nanorods*. Mat Lett*. 62:743–746 Palanisamy P & Raichur AM (2009) Synthesis of spherical NiO nanoparticles through a novel biosurfactant mediated emulsion technique. *Mater Scie Eng C*. 29:199–204 Park SY & Kim Y (2009) Surfactin inhibits immunostimulatory function of macrophages

Park SY, Kim YH, Kim EK, Ryu EY & Lee SJ (2010) Heme oxygenase-1 signals are involved

Pecci Y, Rivardo F, Martinotti MG & Allegrone G (2010) LC/ESI-MS/MS characterisation of

Perfumo A, Banat IM, Canganella F & Marchant R (2006) Rhamnolipid production by a

Perfumo A, Smyth TJP, Marchant R & Banat IM (2010a) Production and roles of

Perfumo A, Rancich I & Banat IM (2010b). Possibilities and challenges for biosurfactants

Petrelli D, Zampaloni C, D'Ercole S, Prenna M, Ballarini P, Ripa S & Vitali LA (2006)

Peypoux F, Bonmatin JM & Wallach J (1999) Recent trends in the biochemistry of surfactin.

Peypoux F, Guinand M, Michel G, Delcambe L, Das BC & Lederer E (1978) Structure of iturin A, a peptidolipid antibiotic from *Bacillus subtilis*. *Biochemistry.* 17:3992–3996 Peypoux F, Pommier MT, Marion D, Ptak M, Das BC & Michel G 1986. Revised structure of

Owen D & Fan L (2010) Polymeric Biosufactants. US Patent 20100144643, 6 October

membranes. *Biochim Biophys Acta.* 1778:2806–2813

*Phys Lipids.* 158:46–53

51:973-982

188:437-45

*Spectrom.* 45:772–778

*Appl Microbiol*. 75:132-138

Verlag, Berlin Heidelberg, Germany

145, Landes Bioscience, Austin, TX

*Appl Microbiol Biotechnol.* 51*:*553–563

*Microbiol Infect Dis.* 25:773-781

39:636–641

*Rhodococcus* sp. biosurfactant trehalose lipid with phosphatidylethanolamine

bacterial biosurfactant trehalose lipid with phosphatidylserine membranes. *Chem* 

through blocking NK-κB, MAPK and Akt pathway. *Int Immunopharmacol*. 9:886–893

in preferential inhibition of pro-inflammatory cytokine release by surfactin in cells activated with *Porphyromonas gingivalis* lipopolysaccharide. *Chem Biol Interact.*

lipopeptide biosurfactants produced by the *Bacillus licheniformis* V9T14 strain *J Mass* 

novel thermotolerant hydrocarbon-degrading *Pseudomonas aeruginosa AP02-1*. *J* 

biosurfactants and bioemulsifiers in accessing hydrophobic substrates, In: *Handbook of Hydrocarbon and Lipid Microbiology,* Timmis KN Ed., pp. 1501-1512, Springer-

uses in petroleum industry, In: *Biosurfactants*, *BIOSURFACTANTS Book Series: Advances in Experimental Medicine and Biology*, Sen R Ed., Volume: 672, pp. 135-

Analysis of different genetic traits and their association with biofilm formation in *Staphylococcus epidermidis* isolates from central venous catheter infections. *Eur J Clin* 

mycosubtilin, a peptidolipid antibiotic from *Bacillus subtilis*. *J. Antibiot*. (Tokyo)


Rivardo F, Turner RJ, Allegrone G & Ceri H, Martinotti MG (2009) Anti-adhesion activity of

Rodrigues L, Banat IM, Teixeira J & Oliveira R (2006a) Biosurfactants: potential applications

Rodrigues L, van der Mei H, Banat IM, Teixeira J & Oliveira R (2006b) Inhibition of

Rodrigues L, van der Mei HC, Teixeira J & Oliveira R (2004a) Biosurfactant from *Lactococcus* 

Rodrigues L, van der Mei HC, Teixeira J & Oliveira R (2004b) Influence of biosurfactants

Rodrigues L, Banat IM, van der Mei HC, Teixeira JA, Oliveira R & Oliveira R (2006c)

Rodrigues L, Banat IM, Teixeira J & Oliveira R (2007) Strategies for the prevention of

Rodrigues LR, Teixeira JA, van der Mei HC & Oliveira R (2006d) Physicochemical and

Rodrigues LR & Teixeira JA (2010) Biomedical and therapeutic applications of

Rosenberg E & Ron EZ (1999) High- and low-molecular-mass microbial surfactants. *Appl* 

Rosenberg E, Zuckerberg A, Rubinovitz C & Gutnick DL (1979) Emulsifier of *Arthrobacter* RAG-1:isolation and emulsifying properties. *Appl Environ Microbiol.* 37:402–408 Rosenberg M (2006) Microbial adhesion to hydrocarbons: twenty-five years of doing MATH.

Rufino RD, Luna JM, Sarubbo LA, Rodrigues LR, Teixeira JA & Campos-Takaki GM (2011)

Saini HS, Barragán-Huerta BE, Lebrón-Paler A, Pemberton JE, Vázquez RR, Burns AM,

Sánchez M, Aranda FJ, Teruel JA, Espuny MJ, Marqués A, Manresa Á & Ortiz A (2010)

*Candida lipolytica* UCP 0988. *Colloids Surf B Biointerfaces.* 84:1-5

physicochemical and biological properties. *J Nat Prod.* 71:1011–1015

Antimicrobial and anti-adhesive potential of a biosurfactant Rufisan produced by

Marron MT, Seliga CJ, Gunatilaka AA & Maier RM (2008) Efficient purification of the biosurfactant viscosin from *Pseudomonas libanensis* strain M9-3 and its

Permeabilization of biological and artificial membranes by a bacterial dirhamnolipid produced by *Pseudomonas aeruginosa*. *J Colloid Interface Sci*. 341:240–

Ron EZ & Rosenberg E (2001) Natural roles of biosurfactants*. Environ Microbiol*. 3:229–236 Rosenberg E & Ron EZ (1997) Bioemulsans: microbial polymeric emulsifiers. *Curr Opin* 

bacterial pathogens. *Appl Microbiol Biotechnol.* 83:541–553

thermophilus A. *FEMS Immunol Med Microbiol.* 46:107–112

in medicine. *J Antimicrob Chemother.* 57:609–618

66:306-311.

100:470–480.

*Microbiol* 70:4408-4410.

*B Appl Biomater.* 81B:358-370.

*Biotechnol.* 8:313–316

247

*Microbiol Biotechnol* 52:154–162

*FEMS Microbiol Lett.* 262:129–134

*Colloids Surf B Biointerfaces*. 49:79–86

biosurfactants. *Adv Exp Med Biol*. 672:75-87

two biosurfactants produced by *Bacillus* spp. prevents biofilm formation of human

microbial adhesion to silicone rubber treated with biosurfactant from Streptococcus

*lactis* 53 inhibits microbial adhesion on silicone rubber. *Appl Microbiol Biotechnol.* 

from probiotic bacteria on formation of biofilms on voice prosthesis. *Appl Environ* 

Interference in adhesion of bacteria and yeasts isolated from explanted voice prostheses to silicone rubber by rhamnolipid biosurfactants. *J Appl Microbiol*.

microbial biofilm formation on silicone rubber voice prostheses. *J Biomed Mater Res* 

functional characterization of a biosurfactant produced by *Lactococcus lactis* 53.


Smyth TJP, Perfumo A, Marchant R & Banat IM (2010a) Isolation and analysis of low

Smyth TJ, Perfumo A, Marchant R, Banat IM, Chen M, Thomas RK, Penfold J, Stevenson PS

Smyth TJP, Perfumo A, McClean S, Marchant R & Banat IM (2010c) Isolation and analysis of

Sotirova AV, Spasova DI, Galabova DN, Karpenko E & Shulga A (2008) Rhamnolipid–

Stepanovic S, Cirkovic I, Ranin L & Svabic-Vlahovic M (2004) Biofilm formation by

Stickler DJ (2008) Bacterial biofilms in patients with indwelling urinary catheters. *Nat Clin* 

Suzuki M, Kitagawa M, Yamamoto S, Sogabe A, Kitamoto D, Morita T, Fukuoka T & Imura

Tanaka Y, Tojo T, Uchida K, Uno J, Uchida Y & Shida O (1997) Method of producing iturin A and antifungal agent for profound mycosis*. Biotechnol Adv.* 15:234–235 Tang JS, Zhao F, Gao H, Dai Y, Yao ZH, Hong K, Li J, Ye WC & Yao XS (2010)

economically cheaper sources. *World J Microbiol Biotechnol.* 24:917-925 Thavasi R, Jayalakshmi S & Banat IM (2011) Effect of biosurfactant and fertilizer on

Ueno Y, Hirashima N, Inoh Y, Furuno T & Nakanishi M (2007a) Characterization of

Ueno Y, Inoh Y, Furuno T, Hirashima N, Kitamoto D & Nakanishi M (2007b) NBD-

*Microbiology*, Timmis KN Ed., pp. 3705-3723, Springer, Berlin,

*Biotechnol*. 87:1347-1354

strains. *Curr Microbiol.* 56:639–644

Germany

38:428–432

7 January

778

*Pharm Bull.* 30:169–172

*Release*. 123:247–253

*Pract Urol.* 5:598-608

molecular weight microbial glycolipids, In: *Handbook of Hydrocarbon and Lipid* 

& Parry NJ (2010b) Directed microbial biosynthesis of deuterated biosurfactants and potential future application to other bioactive molecules. *Appl Microbiol* 

lipopeptides and high molecular weight biosurfactants, In: *Handbook of Hydrocarbon and Lipid Microbiology*, Timmis KN Ed., pp. 3689–3704, Springer, Berlin, Germany Soberón-Chávez G & Maier RM (2010) Biosurfactants: a general overview, In: *Biosurfactants:* 

*From Genes to Applications,* Soberón-Chávez G Ed., pp. 1-11, Springer, Münster,

biosurfactant permeabilizing effects on gram-positive and gram-negative bacterial

*Salmonella* spp. and *Listeria monocytogenes* on plastic surface. *Lett Appl Microbiol.*

T (2010) Activator including biosurfactant as active ingredient, mannosyl erythritol lipid, and production method publication. Patent application number: 20100168405,

Characterization and online detection of surfactin isomers based on HPLC-MSn analyses and their inhibitory effects on the overproduction of nitric oxide and the release of TNF-α and IL-6 in LPS-induced macrophages. *Mar Drugs*. 8:2605-2618. Thavasi R, Jayalakshmi S, Balasubramanian T & Banat IM (2008) Production and

characterization of a glycolipid biosurfactant from *Bacillus megaterium* using

biodegradation of crude oil by maring isolates of *Bacillus megaterium* and *Corynebacterium kutscheri* and *Pseudomonas aeruginosa*. *Bioresouce Technol.* 102:772-

biosurfactant-containing liposomes and their efficiency for gene transfection. *Biol* 

conjugated biosurfactant (MEL-A) shows a new pathway for transfection. *J Control* 

